| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:52854841:3579 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:52854841:3579?format=raw |
LEADER: 03579fam a2200409 a 4500
001 4049492
005 20221027024447.0
008 950713t19951995gw a b 001 0 eng c
010 $a 95031212
020 $a3540593527 (alk. paper)
035 $a(OCoLC)32922765
035 $a(OCoLC)ocm32922765
035 $9AKZ9570HS
035 $a(NNC)4049492
035 $a4049492
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB
050 00 $aRC669.9$b.E53 1995
060 10 $aWG 500 E565 1995
082 00 $a616.1$220
245 04 $aThe endothelium in cardiovascular disease :$bpathophysiology, clinical presentation, and pharmacotherapy /$cThomas F. Luscher (ed.).
260 $aBerlin ;$aNew York :$bSpringer,$c[1995], ©1995.
300 $axi, 197 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $tThe Endothelium as a Regulator of Vascular Tone and Growth /$rT. F. Luscher and G. Noll --$tEffects of Physical and Pharmacological Interventions on Circulating Endothelin-1 Levels in Humans /$rA. Morganti, F. Ghio and G. Gazzano --$tThe Role of Endothelin in Congestive Heart Failure /$rA. L. Clavell and J. C. Burnett, Jr. --$tEndothelin as a Regulator of Vascular Tone in Man: Studies in Upper Limb Resistance and Capacitance Vessels /$rD. J. Webb, W. G. Haynes and C. J. Ferro --$tSystemic and Endocrine Effects of Endothelin in Humans /$rH. Vierhapper --$tEndothelin in Hypertension and Vascular Hypertrophy: Experimental Studies /$rE. L. Schiffrin --$tRole of Endogenous Endothelin in Myocardial Ischemia and Nitric Oxide-Deficient Hypertension /$rV. Richard, M. Hogie and C. Thuillez --$tEndothelin and Renal Function: From Theory to Therapy /$rT. J. Rabelink and P. Morrison --$tThe Endothelium and the Pathogenesis of Chronic Vascular Diseases: The Protective Role of Calcium Antagonists /$rH. Haller --
505 80 $tInsulin and the Regulation of the Cardiovascular System: Role of the L-arginine Nitric Oxide Pathway and the Sympathetic Nervous System /$rU. Scherrer --$tEndothelin Receptor Antagonists as New Tools to Inhibit Endothelin induced Vasoconstriction in Humans: Comparison with Calcium Channel Blockers /$rR. R. Wenzel and T. F. Luscher --$tEndothelial Dysfunction: Clinical Applicability of Calcium Antagonist Drugs /$rH. L. Elliott --$tEndothelin in Hypertension and Diabetes Mellitus /$rA. Fernandez-Cruz, R. Patino, J. Ibarra, L. Fernandez, M. Roldan, J. Moya and R. Fernandez-Durango --$tEndothelium-Dependent Vasodilation in the Peripheral Circulation in Humans In Vivo: Effects of Hypertension and Aging /$rS. Taddei and A. Salvetti --$tEndothelin and Pulmonary Hypertension /$rD. J. Stewart and D. Langleben.
650 0 $aVascular endothelium$xPathophysiology.
650 0 $aEndothelins$xPathophysiology.
650 0 $aNitric oxide$xPathophysiology.$0http://id.loc.gov/authorities/subjects/sh2010103760
650 12 $aEndothelium, Vascular$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D004730Q000503
650 22 $aEndothelins$xphysiology.$0https://id.nlm.nih.gov/mesh/D016232Q000502
650 22 $aEndothelins$xantagonists & inhibitors.$0https://id.nlm.nih.gov/mesh/D016232Q000037
650 22 $aEndothelium-Dependent Relaxing Factors.$0https://id.nlm.nih.gov/mesh/D045462
650 22 $aCardiovascular Diseases$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D002318Q000503
700 1 $aLüscher, Thomas F.$q(Thomas Felix)$0http://id.loc.gov/authorities/names/n87859238
852 00 $boff,hsl$hRC669.9$i.E53 1995